Literature DB >> 1309900

In vitro resolution of adeno-associated virus DNA hairpin termini by wild-type Rep protein is inhibited by a dominant-negative mutant of rep.

R A Owens1, B J Carter.   

Abstract

An adeno-associated virus (AAV) genome with a Lys-to-His (K340H) mutation in the consensus nucleotide triphosphate binding site of the rep gene has a dominant-negative DNA replication phenotype in vivo. We expressed both wild-type (Rep78) and mutant (Rep78NTP) proteins in two helper-free expression systems consisting of either recombinant baculoviruses in insect cells or the human immunodeficiency virus type 1 long terminal repeat promoter in human 293 cell transient transfections. We analyzed nuclear extracts from both expression systems for the ability to complement uninfected HeLa cell cytoplasmic extracts in an in vitro terminal resolution assay in which a covalently closed AAV terminal hairpin structure is converted to an extended linear duplex. Although both Rep78 and Rep78NTP bound to AAV terminal hairpin DNA in vitro, Rep78 but not Rep78NTP complemented the terminal resolution assay. Furthermore, Rep78NTP was trans dominant for AAV terminal resolution in vitro. We propose that the dominant-negative replication phenotype of AAV genomes carrying the K340H mutation is mediated by mutant Rep proteins binding to the terminal repeat hairpin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309900      PMCID: PMC240835     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV.

Authors:  R J Samulski; A Srivastava; K I Berns; N Muzyczka
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

2.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

3.  In vitro resolution of covalently joined AAV chromosome ends.

Authors:  R O Snyder; R J Samulski; N Muzyczka
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

4.  Mutation of a consensus purine nucleotide binding site in the adeno-associated virus rep gene generates a dominant negative phenotype for DNA replication.

Authors:  N Chejanovsky; B J Carter
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.

Authors:  D S Im; N Muzyczka
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

6.  Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor.

Authors:  N Chejanovsky; B J Carter
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

7.  Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication.

Authors:  N Chejanovsky; B J Carter
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

8.  Adeno-associated virus rep proteins produced in insect and mammalian expression systems: wild-type and dominant-negative mutant proteins bind to the viral replication origin.

Authors:  R A Owens; J P Trempe; N Chejanovsky; B J Carter
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

9.  Structural and functional homology of parvovirus and papovavirus polypeptides.

Authors:  C R Astell; C D Mol; W F Anderson
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

10.  Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis.

Authors:  S E Straus; E D Sebring; J A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

View more
  19 in total

1.  Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins.

Authors:  J Wu; M D Davis; R A Owens
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy.

Authors:  Terence R Flotte
Journal:  Mol Ther       Date:  2013-11       Impact factor: 11.454

3.  Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro.

Authors:  M D Davis; R S Wonderling; S L Walker; R A Owens
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.

Authors:  X S Wang; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.

Authors:  William B Guggino; Liudmila Cebotaru
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

7.  Interaction of wild-type and mutant adeno-associated virus (AAV) Rep proteins on AAV hairpin DNA.

Authors:  M D Weitzman; S R Kyöstiö; B J Carter; R A Owens
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Biochemical characterization of adeno-associated virus rep68 DNA helicase and ATPase activities.

Authors:  X Zhou; I Zolotukhin; D S Im; N Muzyczka
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein.

Authors:  R O Snyder; D S Im; T Ni; X Xiao; R J Samulski; N Muzyczka
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Asymmetric resolution of a parvovirus palindrome in vitro.

Authors:  S F Cotmore; J P Nüesch; P Tattersall
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.